Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication20122013201420152016201720182019202020212022202320242025 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyClinical Trial UnitProduct Development Jan 2023 Adv Healthc Mater Design and Development of Extracellular Matrix Protein-Based Microcapsules as Tools for Bacteria Investigation Autoren Pashapour S et al. Jan 2023 Nat Immunol Human TH17 cells engage gasdermin E pores to release IL-1alpha on NLRP3 inflammasome activation Autoren Chao Y-Y et al. Jan 2023 Lancet Infect Dis Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage Autoren Arora P et al. Jan 2023 Methods Inf Med Consistency as a Data Quality Measure for German Corona Consensus Items Mapped from National Pandemic Cohort Network Data Collections Autoren Yusuf KO et al. Jan 2023 STAR Protoc Flow cytometric protocol to characterize human memory B cells directed against SARS-CoV-2 spike protein antigens Autoren Weskamm LM Dahlke C Addo MM Jan 2023 Angew Chem Int Edit Persicamidines-Unprecedented Sesquarterpenoids with Potent Antiviral Bioactivity against Coronaviruses Autoren Keller L et al. Jan 2023 PLoS One Suitability and user acceptance of the eResearch system "Prospective Monitoring and Management App (PIA)"-The example of an epidemiological study on infectious diseases Autoren Ortmann J et al. Jan 2023 Adv Sci Towards Translation of PqsR Inverse Agonists: From In Vitro Efficacy Optimization to In Vivo Proof-of-Principle Autoren Hamed MM et al. Jan 2023 J Hepatol A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In Cirrhotics Autoren Anolli MP et al. Jan 2023 Eur J Epidemiol Age-specific contribution of contacts to transmission of SARS-CoV-2 in Germany Autoren Rodiah I et al. Jan 2023 Front Psychiatry Social participation and mental health of immunocompromised individuals before and after COVID-19 vaccination-Results of a longitudinal observational study over three time points Autoren Heesen G et al. Jan 2023 Gastroenterology CagA-specific gastric CD8(+) tissue-resident T cells control Helicobacter pylori during the early infection phase Autoren Koch MR et al. Jan 2023 Int J Infect Dis Heterologous prime-boost immunisation with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study Autoren Kohmer N et al. Jan 2023 Bioorg Chem Synthesis, biological evaluation, and molecular docking studies of aldotetronic acid-based LpxC inhibitors Autoren Wimmer S et al. Jan 2023 Clin Microbiol Infect Clostridioides difficile infection (CDI): A pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI) Autoren Wingen-Heimann SM et al. Jan 2023 Int J Tuberc Lung Dis Co-administration of treatment for drug-resistant TB and hepatitis C Autoren Olaru ID et al. Pagination Previous page ‹‹ Seite 29 Seite 30 Seite 31 Seite 32 Seite 33 Seite 34 Seite 35 Seite 36 Current page 37 Seite 29 Seite 30 Seite 31 Seite 32 Seite 33 Seite 34 Seite 35 Seite 36 Seite 37 Weiter >
Jan 2023 Adv Healthc Mater Design and Development of Extracellular Matrix Protein-Based Microcapsules as Tools for Bacteria Investigation Autoren Pashapour S et al.
Jan 2023 Nat Immunol Human TH17 cells engage gasdermin E pores to release IL-1alpha on NLRP3 inflammasome activation Autoren Chao Y-Y et al.
Jan 2023 Lancet Infect Dis Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage Autoren Arora P et al.
Jan 2023 Methods Inf Med Consistency as a Data Quality Measure for German Corona Consensus Items Mapped from National Pandemic Cohort Network Data Collections Autoren Yusuf KO et al.
Jan 2023 STAR Protoc Flow cytometric protocol to characterize human memory B cells directed against SARS-CoV-2 spike protein antigens Autoren Weskamm LM Dahlke C Addo MM
Jan 2023 Angew Chem Int Edit Persicamidines-Unprecedented Sesquarterpenoids with Potent Antiviral Bioactivity against Coronaviruses Autoren Keller L et al.
Jan 2023 PLoS One Suitability and user acceptance of the eResearch system "Prospective Monitoring and Management App (PIA)"-The example of an epidemiological study on infectious diseases Autoren Ortmann J et al.
Jan 2023 Adv Sci Towards Translation of PqsR Inverse Agonists: From In Vitro Efficacy Optimization to In Vivo Proof-of-Principle Autoren Hamed MM et al.
Jan 2023 J Hepatol A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In Cirrhotics Autoren Anolli MP et al.
Jan 2023 Eur J Epidemiol Age-specific contribution of contacts to transmission of SARS-CoV-2 in Germany Autoren Rodiah I et al.
Jan 2023 Front Psychiatry Social participation and mental health of immunocompromised individuals before and after COVID-19 vaccination-Results of a longitudinal observational study over three time points Autoren Heesen G et al.
Jan 2023 Gastroenterology CagA-specific gastric CD8(+) tissue-resident T cells control Helicobacter pylori during the early infection phase Autoren Koch MR et al.
Jan 2023 Int J Infect Dis Heterologous prime-boost immunisation with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study Autoren Kohmer N et al.
Jan 2023 Bioorg Chem Synthesis, biological evaluation, and molecular docking studies of aldotetronic acid-based LpxC inhibitors Autoren Wimmer S et al.
Jan 2023 Clin Microbiol Infect Clostridioides difficile infection (CDI): A pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI) Autoren Wingen-Heimann SM et al.
Jan 2023 Int J Tuberc Lung Dis Co-administration of treatment for drug-resistant TB and hepatitis C Autoren Olaru ID et al.
